Start your weight loss journey and schedule a complimentary weight loss consultation today
If symptoms persist beyond several weeks, disrupt sleep, or include pain or urgency, evaluation is recommended
Reta Retatrutide is a novel synthetic peptide that acts as a triple agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
How worried you should be depends on how much aspartame you consume
These medications work by suppressing ghrelin often called the hunger hormone and slowing the rate at which food leaves your stomach
#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @DLBHATTMD @CMichaelGibson @TheLancetEndo @TheLancet @iamritu @hvanspall @DrMarthaGulati thelancet.com/journals/lance Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial In individuals with type 2 diabetes inadequately controlled with metformin, orforglipron 12 mg and 36 mg was non-inferior and superior to semaglutide 7 mg and 14 mg with respect to the mean change in HbA1c from baseline to 52 weeks
